Nicotine and Tobacco Research Team (NTRT)

The mission of the Nicotine and Tobacco Research Team (NTRT) is to promote NIDA nicotine and tobacco research interests, primarily across the Institute and NIH; to serve as a clearinghouse of information to NIDA staff on timely information related to nicotine and tobacco research (including Tobacco Regulatory Science); to inform the addiction research community on NIDA activities relating to nicotine and tobacco; to assist NIDA management in evaluating the nicotine and tobacco research portfolio; and to identify and support new research programs and directions as they relate to nicotine and tobacco.

The Core Group of NTRT Program Staff have the majority of the nicotine and tobacco portfolio and serve as a resource to investigators for inquiries regarding research in this area at NIDA. They represent a cross section of expertise such as pre-clinical, clinical, drug development, behavior, services, treatment, and epidemiology.

Goals of the NTRT include:

• Invite speakers to present at NIDA, either in-person or via Webcast. Topics would be rotated across all areas of research supported by NIDA, including: basic neuroscience, behavior, clinical research, therapeutic development, epidemiology, and prevention.
• Provide networking opportunities between NIDA program staff and the nicotine and tobacco research staff of NIH IC’s and other HHS organizations (e.g., NCI, NHLBI, NIAAA, NICHD, FDA, and SAMHSA).
• Meet regularly with NIDA leadership to discuss the NIDA nicotine and tobacco portfolio, ongoing issues, and identify gap areas to further explore.
• Plan and conduct Pre-Conference Workshops and/or Symposia Sessions at the SRNT Annual Meeting, possibly in collaboration with other NIH IC’s and/or FDA CTP staff.  
• Distribute the Nicotine & Tobacco Research Team (NTRT) NEWSLETTER, which includes notifications of high-profile research publications, changes in tobacco regulation, seminars, meetings, funding opportunity announcements and related updates. 

Membership in the NTRT is open to all NIDA extramural and intramural staff.  If you would like to join and/or receive the Nicotine & Tobacco Research Team (NTRT) NEWSLETTER, please contact Flair Lindsey, flindsey@nida.nih.gov

For questions about the Nicotine and Tobacco Research Team, please contact either of the co-chairs, Mary Kautz, kautzm@nida.nih.gov, or Kevin Walton, kevin.walton@nih.gov.  

Core Membership

Investigators considering to apply for NIDA research grants pertaining to nicotine and tobacco are encouraged to contact the relevant Program Staff to discuss their proposal in relation to NIDA research priorities.  You can also review the NIDA strategic plan, which discusses the Institute's research priorities.

Name	Program Staff Title	Branch	Division	Areas of Expertise
Image	Program Officer	Clinical Research Grants Branch	Division of Therapeutics and Medical Consequence	Behavioral treatments (targeting specific neurobehavioral processes) Theory-derived treatment targets and mechanisms of behavior change, adherence, neuromodulation Integration of behavioral/ pharmacological and technology-based treatment
Image	Training Coordinator	Office of the DNB Director	Division of Neuroscience and Behavior	Institutional and individual research training grants (T32, F30, F31 and F32 awards) Career development awards (K01, K03, K06, K99/R00) Research education grants (R25) Nicotine and tobacco research Basic and clinical research with focus on chemistry, genetics, behavior and functional neuroscience
Image	Deputy Director	Office of the Director	Office of the Director	Population sciences (epidemiology, comorbidity, health services) Research training Research workforce diversity Health disparities research NIDA and FDA PATH Study DHHS Tobacco Control Committee
Image	Health Scientist Administrator	Epidemiology Research Branch	Division of Epidemiology, Services and Prevention Research	Epidemiology and surveillance of tobacco use Marketing, point-of-sale, social media Cognitive and affective factors related to tobacco use.
Image	Program Officer	Behavioral and Cognitive Neuroscience Branch	Division of Neuroscience and Behavior	Cognitive neuroscience and neurobiological mechanistic investigation of nicotine use disorders Focus on studies employing neuroimaging (MRI, EEG, others) and non-invasive brain stimulation Disease trajectory and manipulations of nicotine state (sated/abstinent)
Image	Medical Officer	Services Research Branch	Division of Epidemiology, Services and Prevention Research	Tobacco and nicotine use in the context of polysubstance use Implementation science related to smoking cessation services provision Mobile and digital technology supporting smoking cessation
Image	Health Scientist Administrator	Clinical Research Grants Branch	Division of Therapeutics and Medical Consequences	Human behavioral pharmacology of nicotine/tobacco Smoking behavior, and clinical trials focused on treatment development Behavioral economic and smoking topography assessments Interactions between nicotine/tobacco and other medications/other drug use Smoking cessation medications development research Smoking during pregnancy/smoking cessation interventions targeting people who are pregnant
Image	Director, NIDA Tobacco Regulatory Science Program Officer	Behavioral and Cognitive Neuroscience Branch	Division of Neuroscience and Behavior	NIH-FDA Tobacco Regulatory Science Program (TRSP) Liaison Human and animal studies on behavioral, cognitive, and neurobiological antecedents of exposure to nicotine and other drug use Mechanisms underlying consequences of the various phases of substance use
Image	The PATH Study Director at NIH Program Officer	Epidemiology Research Branch	Division of Epidemiology, Services and Prevention Research	Epidemiology of tobacco use comorbidity with psychiatric disorders Polysubstance use Genetic and environmental risk factors Marketing, point-of-sale, social media, and risk perceptions
Image	Branch Chief Director, NIDA Drug Supply Program	Chemistry and Pharmaceutics Branch	Division of Therapeutics and Medical Consequences	NIDA Drug Supply Program Therapeutic development for drug use treatment Contracts aimed at creating cGMP active pharmaceutical ingredients for human clinical trials
Image	Program Analyst	Behavioral and Cognitive Neuroscience Branch	Division of Neuroscience and Behavior	NIH-FDA Tobacco Regulatory Science Program (TRSP) TRSP career development awards (K01, K99) Nicotine and Tobacco Research Team (NTRT) newsletter, web page and group Research training Health disparities Workforce diversity
Image	Scientific Program Manager	Behavioral and Cognitive Neuroscience Branch	Division of Neuroscience and Behavior	NIH-FDA Tobacco Regulatory Science Program (TRSP) Neuropsychological effects of tobacco/nicotine products using EEGs NIDA Drug Supply Program (Nicotine Research Cigarettes)
Image	Branch Chief	Genetics, Epigenetics, and Developmental Neuroscience Branch	Division of Neuroscience and Behavior	Genetics of substance use disorder Genetics and epigenetics of nicotine dependence Pharmacogenomics of smoking cessation.
Image	Program Officer	Prevention Research Branch	Division of Epidemiology, Services and Prevention Research	Adolescent and young adult vaping and tobacco use Knowledge, attitudes and beliefs about tobacco products and use Mass media health communication campaigns; Digital advertising Survey design Cognitive and developmental psychology Learning and attention
Image	Program Officer	Integrative Neuroscience Branch	Division of Neuroscience and Behavior	Cellular and molecular neurobiology of addiction SUD-related neuroinflammation in animal models. Neuroimmue mechanisms as therapeutic targets for SUD and comorbidities.
No Photo Available  Vemuri, Kiran	Program Officer	Chemistry and Pharmacology Branch	Division of Neuroscience and Behavior	Organic Synthesis Chemical Biology Analytical Chemistry Tool/Probe Development Therapeutics Discovery
Image	Branch Chief	Clincial Research Grants Branch	Division of Therapeutics and Medical Consequences	Clinical trials evaluating new therapeutics or treatment paradigms for smoking cessation Repurposing of approved therapeutics Neuromodulatory/neurostimulatory treatments Integrated pharmacologic and behavioral therapies Co-morbid conditions Electronic cigarettes for harm reduction and nicotine cessation.

Tobacco Regulatory Science Program (TRSP) Funding Opportunities Announcements (FOAs) and Notices

• The Tobacco Regulatory Science (R01 Clinical Trial Optional) - RFA-OD-21-002
• Secondary Analyses of Existing Datasets of Tobacco Use and Health (R21 Clinical Trial Not Allowed) - RFA-OD-21-003
• Maximizing the Scientific Value of Existing Biospecimen Collections (R21 - Clinical Trial Not Allowed) - RFA-OD-21-004
• Notice of Intent to Publish the Reissuance of RFA-OD-20-008 Mentored Research Scientist Career Development Award in Tobacco Regulatory Research (K01 non-clinical trial) - NOT-OD-22-081.
• Notice of Intent to Publish the Reissuance of RFA-OD-20-011 Mentored Research Scientist Career Development Award in Tobacco Regulatory Research (K01 clinical trial required) - NOT-OD-22-082.
• Notice of Intent to Publish the Reissuance of RFA-OD-20-009  Pathway to Independence Award in Tobacco Regulatory Research (K99/R00 non-clinical trial) - NOT-OD-22-083.
• Notice of Intent to Publish the Reissuance of RFA-OD-20-010 Pathway to Independence Award in Tobacco Regulatory Research (K99/R00 clinical trial) - NOT-OD-22-084.

Other Funding Opportunities and Notices

• Electronic Nicotine Delivery Systems (ENDS) and Alternative Nicotine & Tobacco Delivery Systems: Basic Mechanisms of Health Effects - Notice of Special Interest - NOT-OD-22-022
• Electronic Nicotine Delivery Systems (ENDS) and Alternative Nicotine and Tobacco Delivery Systems: Population, Clinical and Applied Prevention Mechanisms of Health Effects - Notice of Special Interest - NOT-OD-22-023
• Public Policy Effects on Alcohol-, Cannabis-, Tobacco-, and Other Drug-Related Behaviors and Outcomes - Notice of Special Interest - NOT-AA-21-028 
• Population Assessment of Tobacco and Health (PATH) Study Biospecimen Access (X01) - PAR-21-044 (X01)
• Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R34 - Clinical Trial Optional) - PA-21-180 (R34)